Protein Expression Market By Product (Reagents, Expression vectors, Competent cells, Instruments and Services), Application (Therapeutic, Industrial, Research): Global Opportunity Analysis and Industry Forecast, 2019–2026
The global protein expression market was valued at $2,121 million in 2018 and is projected to reach $4,611 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.
Protein expression refers to a biotechnological process of generating specific protein, typically attained by manipulation of gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled expression and isolation of recombinant proteins in large scale. One of the major achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to completely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellularly operating enzymes though therapeutic protein. The first expression platform established was prokaryotic system through Escherichia coli. This was followed by development of other expression systems including yeast, algae, insect, and mammalian.
The factors that boost the growth of the protein expression market include surge in geriatric population and increase in prevalence of chronic diseases such as cancer. Moreover, increase in spending on protein research also fuel the growth of the protein expression market. However, high monetary inputs associated with the production of protein products restrict the growth of the market. In addition, significant shortage of trained healthcare professionals and lack of local expertise also restrains the market. Conversely, emergence of microfluids, along with growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.
The global protein expression market is segmented on the basis of product, application, and region. On the basis of product, it is divided into reagents, expression vectors, competent cells, instruments, and services. By application, it is divided into therapeutic, industrial, and research. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
By Product
Protein expression refers to a biotechnological process of generating specific protein, typically attained by manipulation of gene expression in an organism such that it expresses large amounts of a recombinant gene. The development of genetic engineering and recombinant technologies has opened many possibilities of expression and isolation of heterologous proteins for research, clinical, and industrial purposes. Considerable advances in biotechnology have enabled expression and isolation of recombinant proteins in large scale. One of the major achievements is the development of recombinant proteins capable of entering a cell. Such developments lead to completely new opportunities in therapeutic medicine by targeting intracellular mechanisms or by substituting intracellularly operating enzymes though therapeutic protein. The first expression platform established was prokaryotic system through Escherichia coli. This was followed by development of other expression systems including yeast, algae, insect, and mammalian.
The factors that boost the growth of the protein expression market include surge in geriatric population and increase in prevalence of chronic diseases such as cancer. Moreover, increase in spending on protein research also fuel the growth of the protein expression market. However, high monetary inputs associated with the production of protein products restrict the growth of the market. In addition, significant shortage of trained healthcare professionals and lack of local expertise also restrains the market. Conversely, emergence of microfluids, along with growth potential in emerging economies is expected to create lucrative opportunities for the market during the forecast period.
The global protein expression market is segmented on the basis of product, application, and region. On the basis of product, it is divided into reagents, expression vectors, competent cells, instruments, and services. By application, it is divided into therapeutic, industrial, and research. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, the UK, Italy, Spain, France, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific) and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current protein expression market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment
- The market forecast is studied from 2019 to 2026
- The market size and estimations are based on a comprehensive analysis of key developments in the industry
- A qualitative analysis based on innovative products facilitates strategic business planning
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
By Product
- Reagents
- Expression vectors
- Competent cells
- Instruments
- Services
- Therapeutic
- Industrial
- Research
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Latin America
- Middle-East
- Rest of LAMEA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET DYNAMICS
3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Top player positioning
3.4. Market dynamics
3.5. Drivers
3.5.1. Surge in prevalence of chronic disease
3.5.2. Surge in healthcare expenditure worldwide:
3.6. Restraint
3.6.1. Stringent regulatory approval
3.7. Opportunities
3.7.1. Rise in pharmaceutical market in emerging regions
CHAPTER 4: GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT
4.1 Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.3. Expression Vectors
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Competent Cells
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.5. Instruments
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.6. Services
4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast, by region
CHAPTER 5: PROTEIN EXPRESSION MARKET, BY APPLICATION
5.1.1. OVERVIEW
5.1.2. Market size and forecast
5.2. Therapeutic
5.2.1. Market size and forecast, by region
5.3. Industrial
5.3.1. Market size and forecast, by region
5.4. Research
5.4.1. Market size and forecast, by region
CHAPTER 6: PROTEIN EXPRESSION MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America Protein Expression Market, by country
6.2.2.1. U.S.
6.2.2.1.1 U.S. market size and forecast, by product
6.2.2.1.2 U.S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1 Canada market size and forecast, by application
6.2.2.3. Mexico
6.2.2.3.1 Mexico market size and forecast, by product
6.2.2.3.2 Mexico market size and forecast, application
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe protein expression market, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by product
6.3.2.1.2. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1 France market size and forecast, by product
6.3.2.2.2 France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1 UK market size and forecast, by product
6.3.2.3.2 UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1 Italy market size and forecast, by product
6.3.2.4.2 Italy market size and forecast, by application
6.3.2.5. Spain
6.3.2.5.1 Spain market size and forecast, by product
6.3.2.5.2 Spain market size and forecast, by application
6.3.2.6. Rest of Europe
6.3.2.6.1 Rest of Europe market size and forecast, by product
6.3.2.6.2 Rest of Europe market size and forecast, by application
6.3.2.6.3 Europe market size and forecast, by product
6.3.2.6.4 Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific Protein Expression market, by country
6.4.2.1. Japan
6.4.2.1.1 Japan market size and forecast, by product
6.4.2.1.2 Japan market size and forecast, by application
6.4.2.2. China
6.4.2.2.1 China market size and forecast, by product
6.4.2.2..2 China market size and forecast, by application
6.4.2.3. India
6.4.2.3.1 India market size and forecast, by application
6.4.2.4. Rest of Asia-Pacific
6.4.2.4.1 Rest of Asia-Pacific market size and forecast, by product
6.4.2.4.2 Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by PRODUCT
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA protein expression market, by country
6.5.2.1. Latin America
6.5.2.2. Middle East
6.5.2.3. Rest of LAMEA
6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. AGILENT TECHNOLOGIES, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. BECTON, DICKINSON AND COMPANY
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BIO-RAD LABORATORIES, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.4. GenScript Biotech Corporation
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. LifeSensors Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Merck KGaA
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Promega Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. QIAGEN N.V.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Takara Holdings Inc.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. THERMO FISHER SCIENTIFIC, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET DYNAMICS
3.1. Market definition and scope
3.2. Porter's five forces analysis
3.3. Top player positioning
3.4. Market dynamics
3.5. Drivers
3.5.1. Surge in prevalence of chronic disease
3.5.2. Surge in healthcare expenditure worldwide:
3.6. Restraint
3.6.1. Stringent regulatory approval
3.7. Opportunities
3.7.1. Rise in pharmaceutical market in emerging regions
CHAPTER 4: GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT
4.1 Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast, by region
4.3. Expression Vectors
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Competent Cells
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.5. Instruments
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast, by region
4.6. Services
4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast, by region
CHAPTER 5: PROTEIN EXPRESSION MARKET, BY APPLICATION
5.1.1. OVERVIEW
5.1.2. Market size and forecast
5.2. Therapeutic
5.2.1. Market size and forecast, by region
5.3. Industrial
5.3.1. Market size and forecast, by region
5.4. Research
5.4.1. Market size and forecast, by region
CHAPTER 6: PROTEIN EXPRESSION MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America Protein Expression Market, by country
6.2.2.1. U.S.
6.2.2.1.1 U.S. market size and forecast, by product
6.2.2.1.2 U.S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1 Canada market size and forecast, by application
6.2.2.3. Mexico
6.2.2.3.1 Mexico market size and forecast, by product
6.2.2.3.2 Mexico market size and forecast, application
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe protein expression market, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by product
6.3.2.1.2. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1 France market size and forecast, by product
6.3.2.2.2 France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1 UK market size and forecast, by product
6.3.2.3.2 UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1 Italy market size and forecast, by product
6.3.2.4.2 Italy market size and forecast, by application
6.3.2.5. Spain
6.3.2.5.1 Spain market size and forecast, by product
6.3.2.5.2 Spain market size and forecast, by application
6.3.2.6. Rest of Europe
6.3.2.6.1 Rest of Europe market size and forecast, by product
6.3.2.6.2 Rest of Europe market size and forecast, by application
6.3.2.6.3 Europe market size and forecast, by product
6.3.2.6.4 Europe market size and forecast, by application
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific Protein Expression market, by country
6.4.2.1. Japan
6.4.2.1.1 Japan market size and forecast, by product
6.4.2.1.2 Japan market size and forecast, by application
6.4.2.2. China
6.4.2.2.1 China market size and forecast, by product
6.4.2.2..2 China market size and forecast, by application
6.4.2.3. India
6.4.2.3.1 India market size and forecast, by application
6.4.2.4. Rest of Asia-Pacific
6.4.2.4.1 Rest of Asia-Pacific market size and forecast, by product
6.4.2.4.2 Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by PRODUCT
6.4.4. Asia-Pacific market size and forecast, by application
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA protein expression market, by country
6.5.2.1. Latin America
6.5.2.2. Middle East
6.5.2.3. Rest of LAMEA
6.5.3. LAMEA market size and forecast, by product
6.5.4. LAMEA market size and forecast, by application
CHAPTER 7: COMPANY PROFILES
7.1. AGILENT TECHNOLOGIES, INC.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. BECTON, DICKINSON AND COMPANY
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BIO-RAD LABORATORIES, INC.
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.4. GenScript Biotech Corporation
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. LifeSensors Inc.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Merck KGaA
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Promega Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. QIAGEN N.V.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.9. Takara Holdings Inc.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.10. THERMO FISHER SCIENTIFIC, INC.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 01. PROTIEN EXPRESSION MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. PROTEIN EXPRESSION MARKET FOR REAGENTS, BY REGION 2018–2026 ($MILLION)
TABLE 03. PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION 2018–2026 ($MILLION)
TABLE 04. PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION 2018–2026 ($MILLION)
TABLE 05. PROTEIN EXPRESSION MARKET FOR INSTRUMNETS, BY REGION 2018–2026 ($MILLION)
TABLE 06. PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION 2018–2026 ($MILLION)
TABLE 07. PROTIEN EXPRESSION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08. PROTEIN EXPRESSION MARKET FOR THERAPEUTIC, BY REGION 2018–2026 ($MILLION)
TABLE 09. PROTEIN EXPRESSION MARKET FOR INDUSTRIAL, BY REGION 2018–2026 ($MILLION)
TABLE 10. PROTEIN EXPRESSION MARKET FOR RESEARCH, BY REGION 2018–2026 ($MILLION)
TABLE 11. PROTEIN EXPRESSION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 13. U.S. PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 14. U.S. PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 15. CANADA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 16. CANADA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 17. MEXICO PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 18. MEXICO PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 19. EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. GERMANY PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 21. GERMANY PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 22. FRANCE PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 23. FRANCE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 24. UK PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 25. UK PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 26. ITALY PRODUCT EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 27. ITALY PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 28. SPAIN PROTEIN EXPRESSION REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 29. SPAIN PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 30. REST OF EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 31. REST OF EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 32. EUROPE PROTEIN EXPRESION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 33. EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 34. ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. JAPAN PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 36. JAPAN PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 37. CHINA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 38. CHINA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 39. INDIA PROTIEN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 40. INDIA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 41. REST OF ASIA-PACIFIC PROTIEN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 42. REST OF ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 43. ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 44. ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 45. LAMEA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46. LATIN AMERICA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 47. LATIN AMERICA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 48. MIDDLE EAST PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 49. MIDDLE EAST PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 50. REST OF LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 51. REST OF LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 52. LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 53. LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 54. AGILENT: COMPANY SNAPSHOT
TABLE 55. AGILENT: OPERATING SEGMENTS
TABLE 56. AGILENT: PRODUCT PORTFOLIO
TABLE 57. BD: SNAPSHOT
TABLE 58. BD: OPERATING SEGMENTS
TABLE 59. BD: PRODUCT PORTFOLIO
TABLE 60. BIO-RAD: COMPANY SNAPSHOT
TABLE 61. BIO-RAD: OPERATING SEGMENTS
TABLE 62. BIO-RAD: PRODUCT PORTFOLIO
TABLE 63. GENSCRIPT: COMPANY SNAPSHOT
TABLE 64. GENSCRIPT: OPERATING SEGMENTS
TABLE 65. GENSCRIPT: PRODUCT PORTFOLIO
TABLE 66. LIFESENSORS: COMPANY SNAPSHOT
TABLE 67. LIFESENSORS: PRODUCT PORTFOLIO
TABLE 68. MERCK GROUP: COMPANY SNAPSHOT
TABLE 69. MERCK GROUP: OPERATING SEGMENTS
TABLE 70. MERCK GROUP: PRODUCT PORTFOLIO
TABLE 71. PROMEGA: COMPANY SNAPSHOT
TABLE 72. PROMEGA: PRODUCT PORTFOLIO
TABLE 73. QIAGEN: COMPANY SNAPSHOT
TABLE 74. QIAGEN: OPERATING SEGMENTS
TABLE 75. QIAGEN: PRODUCT PORTFOLIO
TABLE 76. TAKARA: COMPANY SNAPSHOT
TABLE 77. TAKARA: OPERATING SEGMENTS
TABLE 78. TAKARA: PRODUCT PORTFOLIO
TABLE 79. THERMO FISHER: COMPANY SNAPSHOT
TABLE 80. THERMO FISHER: OPERATING SEGMENTS
TABLE 81. THERMO FISHER: PRODUCT PORTFOLIO
TABLE 01. PROTIEN EXPRESSION MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. PROTEIN EXPRESSION MARKET FOR REAGENTS, BY REGION 2018–2026 ($MILLION)
TABLE 03. PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY REGION 2018–2026 ($MILLION)
TABLE 04. PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY REGION 2018–2026 ($MILLION)
TABLE 05. PROTEIN EXPRESSION MARKET FOR INSTRUMNETS, BY REGION 2018–2026 ($MILLION)
TABLE 06. PROTEIN EXPRESSION MARKET FOR SERVICES, BY REGION 2018–2026 ($MILLION)
TABLE 07. PROTIEN EXPRESSION MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08. PROTEIN EXPRESSION MARKET FOR THERAPEUTIC, BY REGION 2018–2026 ($MILLION)
TABLE 09. PROTEIN EXPRESSION MARKET FOR INDUSTRIAL, BY REGION 2018–2026 ($MILLION)
TABLE 10. PROTEIN EXPRESSION MARKET FOR RESEARCH, BY REGION 2018–2026 ($MILLION)
TABLE 11. PROTEIN EXPRESSION MARKET, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 13. U.S. PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 14. U.S. PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 15. CANADA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 16. CANADA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 17. MEXICO PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 18. MEXICO PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 19. EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 20. GERMANY PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 21. GERMANY PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 22. FRANCE PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 23. FRANCE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 24. UK PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 25. UK PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 26. ITALY PRODUCT EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 27. ITALY PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 28. SPAIN PROTEIN EXPRESSION REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 29. SPAIN PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 30. REST OF EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 31. REST OF EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 32. EUROPE PROTEIN EXPRESION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 33. EUROPE PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 34. ASIA-PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 35. JAPAN PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 36. JAPAN PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 37. CHINA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 38. CHINA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 39. INDIA PROTIEN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 40. INDIA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 41. REST OF ASIA-PACIFIC PROTIEN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 42. REST OF ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 43. ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 44. ASIA-PACIFIC PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 45. LAMEA PROTEIN EXPRESSION MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 46. LATIN AMERICA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT TYPE, 2019–2026 ($MILLION)
TABLE 47. LATIN AMERICA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 48. MIDDLE EAST PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 49. MIDDLE EAST PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 50. REST OF LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026 ($MILLION)
TABLE 51. REST OF LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026 ($MILLION)
TABLE 52. LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY PRODUCT, 2019–2026($MILLION)
TABLE 53. LAMEA PROTEIN EXPRESSION MARKET REVENUE, BY APPLICATION, 2019–2026($MILLION)
TABLE 54. AGILENT: COMPANY SNAPSHOT
TABLE 55. AGILENT: OPERATING SEGMENTS
TABLE 56. AGILENT: PRODUCT PORTFOLIO
TABLE 57. BD: SNAPSHOT
TABLE 58. BD: OPERATING SEGMENTS
TABLE 59. BD: PRODUCT PORTFOLIO
TABLE 60. BIO-RAD: COMPANY SNAPSHOT
TABLE 61. BIO-RAD: OPERATING SEGMENTS
TABLE 62. BIO-RAD: PRODUCT PORTFOLIO
TABLE 63. GENSCRIPT: COMPANY SNAPSHOT
TABLE 64. GENSCRIPT: OPERATING SEGMENTS
TABLE 65. GENSCRIPT: PRODUCT PORTFOLIO
TABLE 66. LIFESENSORS: COMPANY SNAPSHOT
TABLE 67. LIFESENSORS: PRODUCT PORTFOLIO
TABLE 68. MERCK GROUP: COMPANY SNAPSHOT
TABLE 69. MERCK GROUP: OPERATING SEGMENTS
TABLE 70. MERCK GROUP: PRODUCT PORTFOLIO
TABLE 71. PROMEGA: COMPANY SNAPSHOT
TABLE 72. PROMEGA: PRODUCT PORTFOLIO
TABLE 73. QIAGEN: COMPANY SNAPSHOT
TABLE 74. QIAGEN: OPERATING SEGMENTS
TABLE 75. QIAGEN: PRODUCT PORTFOLIO
TABLE 76. TAKARA: COMPANY SNAPSHOT
TABLE 77. TAKARA: OPERATING SEGMENTS
TABLE 78. TAKARA: PRODUCT PORTFOLIO
TABLE 79. THERMO FISHER: COMPANY SNAPSHOT
TABLE 80. THERMO FISHER: OPERATING SEGMENTS
TABLE 81. THERMO FISHER: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL PROTEIN EXPRESSION MARKET SEGMENTATION
FIGURE 02. LOW MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03. MODERATE BARGAINING POWER OF BUYER
FIGURE 04. HIGH THREAT OF SUBSTITUTES
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. LOW COMPETITIVE RIVALARY
FIGURE 07. TOP PLAYER POSITIONING, 2018
FIGURE 08. DRIVERS AND RESTRAINTS
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR INDUSTRIAL, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR RESEARCH, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. AGILENT: NET SALES, 2016–2018 ($MILLION)
FIGURE 17. AGILENT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 18. AGILENT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 19. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. BD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 22. BIO-RAD: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. BIO-RAD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. BIO-RAD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. GENSCRIPT: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 28. MERCK GROUP: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. MERCK GROUP: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. MERCK GROUP: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. QIAGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. QIAGEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. QIAGEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. TAKARA: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. TAKARA: NET SALES BY SEGMENTS, 2018 (%)
FIGURE 36. TERUMO: NET SALES, 2016–2018 ($MILLION)
FIGURE 37. THERMO FISCHER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38. THERMO FISCHER: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 01. GLOBAL PROTEIN EXPRESSION MARKET SEGMENTATION
FIGURE 02. LOW MODERATE BARGAINING POWER OF SUPPLIER
FIGURE 03. MODERATE BARGAINING POWER OF BUYER
FIGURE 04. HIGH THREAT OF SUBSTITUTES
FIGURE 05. LOW THREAT OF NEW ENTRANTS
FIGURE 06. LOW COMPETITIVE RIVALARY
FIGURE 07. TOP PLAYER POSITIONING, 2018
FIGURE 08. DRIVERS AND RESTRAINTS
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR REAGENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR EXPRESSION VECTORS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR COMPETENT CELLS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR INSTRUMENTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR SERVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR INDUSTRIAL, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF PROTEIN EXPRESSION MARKET FOR RESEARCH, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. AGILENT: NET SALES, 2016–2018 ($MILLION)
FIGURE 17. AGILENT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 18. AGILENT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 19. BD: NET SALES, 2016–2018 ($MILLION)
FIGURE 20. BD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 21. BD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 22. BIO-RAD: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. BIO-RAD: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. BIO-RAD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. GENSCRIPT: NET SALES, 2016–2018 ($MILLION)
FIGURE 26. GENSCRIPT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 27. GENSCRIPT: REVENUE SHARE BY GEOGRAPHY, 2018 (%)
FIGURE 28. MERCK GROUP: NET SALES, 2016–2018 ($MILLION)
FIGURE 29. MERCK GROUP: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. MERCK GROUP: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. QIAGEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. QIAGEN: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. QIAGEN: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. TAKARA: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. TAKARA: NET SALES BY SEGMENTS, 2018 (%)
FIGURE 36. TERUMO: NET SALES, 2016–2018 ($MILLION)
FIGURE 37. THERMO FISCHER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38. THERMO FISCHER: REVENUE SHARE BY REGION, 2018 (%)
